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1  |  INTRODUC TION
Fipronil is a phenylpyrazole pesticide widely used to control many ag-
ricultural and domestic pests. It has broad- spectrum activity against 
fleas, ticks, mites and lice (Dryden, 2015). It is available to treat fleas 
and ticks in cats and dogs; as an insect bait against cockroaches, ants 
and termites; and widely applied in agriculture for soil treatment, 
seed coating and crop protection (Gupta & Milatovic, 2014).
Fipronil is not licenced to treat laying hens. However, some inter-
national news in 2017 revealed that high fipronil residue levels were 
detected in eggs after poultry was accidentally exposed to this drug 
in the Netherlands and other EU countries (Polet & Smith, 2017). 
In this case, the exposure was unintended; however, in others, the 
reason for which fipronil egg residues have been related to poul-
try is the treatment of a mite, specifically the red mite Dermanyssus 
gallinae.
D. gallinae is the most significant ectoparasite pest in poultry 
(Chauve, 1998). It is found in all production systems, including or-
ganic, intensive, enriched cage or barn (Sparagano et al., 2014). It 
sucks laying hens blood at night and then hides in the crevices and 
litter of poultry houses during the day. Infested laying hens can de-
velop anaemia (Cosoroaba, 2001; Kilpinen, 2005), decrease their 
feed intake, egg production, egg quality (shell thinning, spotting) and 
weight gain, and in severe cases, they may die (Sigognault Flochlay 
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Abstract
This experimental work reproduces the fipronil extra- label administration performed 
by producers in laying hens. The scientific goal was to characterize the residual 
concentrations in eggs from treated hens and suggest the withdrawal periods that 
should be respected to avoid risk for consumers. Thirty- four laying hens were allo-
cated into two groups: Group A was treated with fipronil in feed, two single doses of 
1 mg kg−1 day−1; Group B was administered a single dose of 1 mg kg−1 by the topical 
route. Fipronil egg residues were quantified by HPLC- MS/MS. Fipronil and its sul-
phone metabolite (fipronil- SO2) were measured in egg after both treatments. The 
highest egg residual profile was always for fipronil- SO2. Mean maximum egg concen-
trations (Cmax) of 228.5 ± 79.8 ng/g (fipronil) and 1,849 ± 867 ng/g (fipronil- SO2) were 
found after fipronil administration in feed. The lowest residual levels were quantified 
after the topical treatment with Cmax of 27.1 ± 4.9 and 163 ± 26 ng/g for fipronil and 
fipronil- SO2. Mean fipronil marker residues and established MRLs allowed calculat-
ing the withdrawal periods, the shortest being 74 days after topical administration. 
Such a long withdrawal period is difficult to meet in egg production systems. Thus, 
the extra- label use of fipronil in laying hens should not be recommended under any 
circumstances.
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et al., 2017). D. gallinae can also be involved in the transmission of 
numerous poultry pathogens, including zoonotic pathogens such as 
Salmonella enteritidis (Mul, 2009; Sommer et al., 2016; Valiente Moro 
et al., 2009, 2010).
Consequently, the economic impact of this pest on the poultry 
sector is considerable. In Europe, the annual cost of the red mite 
infestation was estimated at €231 million for productivity losses 
(Sigognault Flochlay et al., 2017; Van Emous, 2017).
The control of D. gallinae is a problem because very few 
drugs have been approved to treat ectoparasites in laying hens. 
Only two active drugs, phoxim and the more recently fluralaner, 
are licenced for red mite treatment of poultry in some countries 
(European Commission, 2017; Prohaczik et al., 2017). The lack of 
accessible drugs to treat the red mite in laying hens has led to ille-
gal extra- label use of acaricides, such as fipronil, in many countries 
(Marmulak et al., 2015; Reich & Triacchini, 2018). The extra- label 
use of different compounds is allowed in particular situations, 
but this practice is very well regulated with laws (Comyn, 2003; 
Directive EC, 2001; FDA, 2019; Government of Canada, 2014) in 
order to prevent the appearance of illegal residues in human food, 
such as meat, eggs, milk and other products. Consequently, the 
rules for legitimate extra- label use of drugs in food animals, in-
cluding poultry, are more restrictive than those for strictly com-
panion animals (Spenser, 2004).
Although extra- label use could be an alternative to control the 
red mite in poultry, the problem with fipronil is that it has not been 
classified as an ‘allowed substance’ for food- producing animals in 
most countries. In the EU, fipronil was only authorized as an insec-
ticide in plant protection (Regulation EC, 2009). It could never have 
been a treatment option for food- producing animals following the 
cascade system (Directive EC, 2001). Additionally, fipronil is an EPA- 
regulated pesticide, and extra- label use of this product is expressly 
prohibited in the United States, including all poultry, either in large 
commercial or small backyard flocks (Stafford et al., 2018).
Despite the aforementioned restrictions, the strong need for ac-
cessible drugs to control the red mite in poultry has led to the illegal 
use of fipronil in many countries (Reich & Triacchini, 2018).
In Argentina, there is an average population of 139 million in-
dustrial birds, including broilers (71%), laying hens (27%), breeding 
parents (1%) and grandparents (1%) (SENASA, 2020). The poultry 
sector is very important because of its contribution to the basic food 
basket, with a great economic impact on both local consumption 
and exports. The fipronil extra- label use is also evident, as a fipronil 
pour- on formulation licenced for cattle has been used for this pur-
pose in egg producing farms for local consumption. In this context, 
in 2015, this research subject was began in our laboratory, aiming 
to answer several questions concerning the kind of treatment per-
formed, the doses used, the occurrence of residues in eggs, among 
others. From conversations with the poultry producers, it was found 
out the type of extra- label fipronil administration that they were ‘hy-
pothetically’ using in laying hens. At the same time, some egg sam-
ples were taken from a farm, and it did indeed find fipronil residues 
in egg (Canton et al., 2018). In this context, the aims of the current 
experimental work were as follows: 1. to reproduce the extra- label 
administrations performed by producers in laying hens in a ‘con-
trolled experimental’ way; 2. to determine the occurrence of fipronil 
residues in eggs after these administrations; 3. to suggest a with-
drawal period for fipronil extra- label use in hens.
2  |  MATERIAL S AND METHODS
2.1  |  Reagents and chemicals
Pure reference standards (99% purity) of fipronil and fipronil- SO2 
were purchased from Toronto Research Chemicals Inc. (Toronto, 
ON, Canada). The acetonitrile solvent used during the extraction 
and drug analysis was HPLC grade and purchased from Sintorgan 
S.A. (Buenos Aires, Argentina). Water was double distilled and 
deionized using a water purification system (Simplicity®; Millipore, 
Sao Paulo, Brazil).
2.2  |  Fipronil treatments
2.2.1  |  Fipronil feed medication (Group A)
Fipronil (Ectoline®, Merial Argentina S.A., fipronil 1%) was adminis-
tered in feed. We considered the following aspects for feed medi-
cation. The administered dose was 1 mg/kg, defined according to 
the extra- label practice used in avian production, whereby 2 L of 
Ectoline (1%) is mixed with 1000 kg of feed (20 g of fipronil/1000 kg 
of feed = 20 µg/g). The daily feed consumption of 150 g/day/hen 
and the average weight of the animals (2.9 kg) were taken into ac-
count. The formulation volume to be administered was mixed in a 
diffuser containing 50 ml of sunflower oil and stirred manually to 
ensure a homogeneous mixture. This mixture was dispersed over the 
food on a tray administered in batches and mixed mechanically (by 
mixer) for 15 min to guarantee a uniform mix. The medicated feed 
was prepared just before administration. As fipronil concentration in 
feed was not checked, it was assumed that the form and time of mix-
ing guarantee the homogeneous drug distribution in feed. However, 
some lack of uniformity in drug mixing could have contributed to the 
variability of fipronil concentrations quantified in egg.
2.2.2  |  Topical fipronil (Group B)
Fipronil (Ectoline®, Merial Argentina S.A., fopronil 1%) was admin-
istered topically at the dose of 1 mg/kg. According to the average 
weight of the animals (2.9 kg), 0.3 ml of the pure formulation was 
administered. Imitating the extra- label practice in poultry produc-
tion, the volume was deposited by two or three drops on the caudal 
half of the animal's dorsal line.
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2.3  |  Experimental design
All the experiments were carried out at “Escuela de Educación 
Secundaria Agraria No1, Dr. Ramón Santamarina” (Tandil, Buenos Aires, 
Argentina), following ethical guidelines of the animal welfare commit-
tee of the Facultad de Medicinina Veterinaria, Universidad Nacional 
del Centro de la Provincia de Buenos Aires (Act 087/02). Thirty- four 
(34) Plymouth Rock Barrada adult laying hens (10– 12 months old, 
2.9 ± 0.4 kg body weight) were involved in the current experiment. The 
hens were housed and acclimated for 10 days with water and balanced 
commercial food (Metrive®) ad libitum. They did not receive any medi-
cation before the experiments. They were allocated into two groups 
(17 animals each) and treated as follows: Group A: Fipronil feed medi-
cation. Hens were treated with fipronil by the oral route in feed (1 mg 
fipronil/kg) prepared as described above. Two administrations were 
carried out, the first one at day 1 and the second one at day 7. Group 
B: Topical route. The hens were administered fipronil by the topical 
route, in one single dose (1 mg fipronil/kg) as described previously. 
Eggs produced daily from the first administration until 35 days post- 
first treatment were collected. Group and sampling day were written 
on the shell for future identification. In the laboratory, the eggs were 
opened, and the yolk and white were mixed (intense manual stirring 
with a spoon for three min) and stored in a plastic tube at −18°C until 
further analysis by HPLC- MS/MS.
2.4  |  Egg analysis
Experimental or fortified egg samples were processed and ana-
lysed by HPLC- MS/MS following a methodology developed in our 
laboratory. Total egg samples (0.5 g) were extracted by the addi-
tion of 1 ml cold acetonitrile under a high- speed vortexing shaker 
for 10 min. After sonication for 10 min, samples were centrifuged 
(4000 rpm, 10 min, 4°C). The clear supernatant was added with 2 ml 
of water and transferred to C18 cartridges (100 mg/ml Strata C18- T, 
Phenomenex, CA, USA) using a manifold vacuum (Baker spe- 24G). 
The cartridges were previously conditioned with 1 ml of methanol 
(HPLC grade), followed by 1 ml of water (HPLC grade). All samples 
were applied and then sequentially washed with 1 ml of water, 1 ml 
of methanol/water (1:4) and 1 ml of hexane, dried with air for 2 min 
and eluted with 2 ml of acetonitrile (HPLC grade). The eluted vol-
ume was evaporated to dryness at 60°C in a vacuum concentrator 
(Speed- Vac, Savant, Los Angeles, CA, USA). The dry residue was 
dissolved in acetonitrile:water (60:40) 2 ml by shaking (10 min) and 
sonication (10 min). The samples were filtered with 0.22 µm nylon 
filters and 5 µl were injected into the chromatographic system.
2.5  |  HPLC- MS/MS system and 
chromatographic condition
Samples were analysed by HPLC- MS/MS using equipment from 
Shimadzu (Kyoto, Japan). The equipment was composed of two HPLC- 
LC- 20AD Prominence pumps, a SIL- 20AC HT Prominence injector, a 
CTO- 20AC Prominence column oven and an LCMS- 8050 triple quad-
rupole mass spectrometer. A Shim- pack HR- ODS C18 analytical col-
umn (15 cm · 3 mm internal diameter, 2.6 mm particle size) at 40ºC in 
the column oven was used for separation. Water (A) and ACN (B) were 
used as the mobile phase at 0.4 ml·min−1 with the following gradient 
programme. Initially, the mobile phase (B) was 60% (0 min), increased 
linearly to 80% B (2 min), followed by a linear increase to 90% B (5 min) 
and decreased to 60% B (5.5 min), which was held until the end of the 
process for 7 min. The injection volume was 5 µl.
The analysis was performed in the negative ion electrospray ion-
ization mode (ESI). Monitoring was done in multiple reaction moni-
toring, with a dwell time of 50 ms. Two transitions were followed for 
each molecule, the first one being the quantifier and the second one 
the qualifier. The temperature parameters for the heated ESI were 
300ºC (interface), 250°C (desolvation line) and 400°C (heat- block). 
The flow rate parameters for heating (air), nebulising (N2) and drying 
gas (N2) were 10, 3 and 10 L min
−1, respectively. The optimization 
procedure for determining individual compounds’ MRM transitions, 
the best quantifier, qualifier ion and collision energies (eV) was made 
by direct injections (0.1 mg·mL−1) in the Mass Spectrometer. Table 1 
lists the retention time, collision energy, and the quantification and 
confirmation ions monitored for fipronil and fipronil- SO2 analytes.
2.6  |  Method validation
A complete validation of the analytical procedures for the extraction 
and quantification of fipronil and fipronil- SO2 in egg was performed 
before the analysis of the experimental samples. Stock and working 
solutions of both standards in methanol were prepared. Parameters 
such as linearity, recovery, limit of detection (LOD), limit of quanti-
fication (LOQ), stability and matrix effect were investigated under 
the optimized extraction conditions. The linearity was tested by 
constructing calibration curves with blank egg samples fortified with 
TA B L E  1  HPLC- MS/MS parameters for fipronil and its fipronil- SO2 metabolite: retention time, ions monitored with the multiple reaction 















Fipronil 5.30 ESI(−) 434.85 329.9 16 249.9 25
FiproniI- SO2 5.77 ESI(−) 450.80 414.9 16 281.95 25
aUsed for quantitation. 
bUsed for confirmation. 
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fipronil and fipronil- SO2 at two ranges of calibration: 10– 100 ng/g 
and 100– 1000 ng/g. The data were analysed for linearity using the 
least- squares regression method, and the Run Test and ANOVA to 
determine whether the data differed from a straight line. The lin-
ear regression lines for fipronil and fipronil- SO2 showed correlation 
coefficients ≥0.998. Mean absolute recovery percentages ranged 
between 78.4 and 85.8%. Precision and accuracy (intra- day and 
inter- day) were determined by the evaluation of replicates (n = 6) of 
drug- free egg samples fortified with each compound at three dif-
ferent concentrations (40, 100 and 1000 ng/g). The evaluation of 
the intra- day precision involved six (n = 6) measurements of the egg 
samples at the three different concentrations within a single run. 
Precision was expressed as the coefficient of variation (%CV). The 
inter- assay precision of the analytical procedures obtained after 
the analysis of fipronil and fipronil- SO2 on different working days 
showed CV between 1.6 and 9.2%. Accuracy of the method was 
measured by the differences between observed and calculated con-
centration results obtained inter- day (6 consecutive working days) 
and expressed as the relative error (%RE) with values between 3.6 
and 17.6%. The long- term stability of each compound was tested 
with blank egg samples fortified at 30 ng/g or 1000 ng/g and stored 
at −20 ºC. Samples (n = 3) were analysed at 0 and 90 days post- 
freezing. Stability given by CV after analyses was between 4.4 and 
17.6%. The LOQ was defined as the lowest drug concentration on 
the standard curve that could be quantitated (n = 6) with a preci-
sion not exceeding 20% and accuracy within 20% of nominal (Snyder 
et al., 1997). The LOQ values were established at 10 ng/g for both 
molecules. Matrix effect (%) was calculated by comparing the cali-
bration curve slopes (CS) within the matrix- matched standards (egg) 
and solvent standards using the following equation:
The matrix effect values were −9.2 and −2.1 for fipronil and 
fipronil- SO2, respectively.
2.7  |  Withdrawal period calculation
The marker residue concentrations (fipronil+fipronil- SO2) measured 
in egg were analysed, and a recommended withdrawal period was 
estimated in egg after both fipronil administrations to laying hens. 
The withdrawal periods were calculated using the results of a lin-
ear regression analysis of the log residual concentrations vs. time of 
the terminal elimination phase. As there are no MRLs for the use of 
fipronil as a medicine in laying hens, similar to reported works (Reich 
& Triacchini, 2018) the MRLs established for this species associ-
ated with the use of fipronil as a pesticide were taken as references. 
The withdrawal period was established at the time when the upper 
one- sided tolerance limit with a given confidence interval (95%) was 
below the different MRLs/tolerance considered 5 ng/g (Commission 
Regulation EU, 2019); 20 ng/g (FAO/WHO, 2019); or 30 ng/g (Code 
of Federal Regulations, 2000). If this time point did not make up a 
full day, the withdrawal period was rounded up to the next day. The 
calculations were done using the ‘Melk WTM 1.4’ withdrawal- time 
calculation computer software (http://www.ema.europe.eu).
2.8  |  Pharmacokinetic and statistical analysis
The peak concentration (Cmax) and time to peak concentration (Tmax) 
were read from the plotted concentration– time curve for each ana-
lyte. The area under the concentration– time curve (AUC) for fipronil/
fironil- SO2 residues in egg was calculated by the trapezoidal rule 
(Gibaldi & Perrier, 1982) using the PK Solution 2.0 software (Summit 
10 Research Services, CO, USA). This parameter and the concen-
tration data are reported as mean ± SD. Statistical comparison was 
carried out by ‘Student´s t test’ using the Instat 3.0 Software (Graph 
Pad Software, San Diego, CA, USA). A value of p < 0.05 was consid-
ered statistically significant.
3  |  RESULTS
3.1  |  Administration of fipronil- medicated feed
Egg residues were detected after fipronil in feed administration to 
laying hens at 1 mg/kg (two doses) at all sampling times (from day 
3 to 35). Fipronil parent drug residues were quantified in egg from 
day 3 to 23, reaching a maximum at day 12 (Cmax: 228.5 ± 79.8 ng/g) 
(Figure 1). The highest egg residual profile was measured for 
fipronil- SO2 (Figure 1). High egg residues of this molecule were 
quantified from day 3 up to the last sampling time. Although a Cmax 
(1,849 ± 867 ng/g) was quantified at day 22, it was not a typical peak 





F I G U R E  1  Mean (±SD) fipronil and fipronil- SO2 (sulphone 
metabolite) egg residue profile vs. time obtained after fipronil 
administration in feed (two single doses of 1 mg kg−1 day−1 at 1 and 


















            Oral administration
Second dose
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then remained in a ‘plateau’ until day 24, and afterwards began to 
decrease very slowly.
Figure 2 shows the egg fipronil concentrations after its ad-
ministration in feed estimated as partial (AUC0- 7 days) or total 
(AUC0- LOQ) area under the curve. Figure 3 shows egg marker 
residues (fipronil+fipronil- SO2) after fipronil administration in 
feed to laying hens. The concentration vs. time curve profile of 
the marker residue was represented mostly by fipronil- SO2, as 
higher concentrations of this metabolite were quantified in eggs, 
compared to the parent fipronil. Peak egg concentration (Cmax) of 
egg marker residue Cmax (1864 ± 866 ng/g) at 22 days was similar 
to fipronil- SO2 Cmax. (1849 ± 867 ng/g). Regarding fipronil max-
imum residue limits (MRLs) allowed in egg— 5 ng/g (Commission 
Regulation EU, 2019); 20 ng/g (FAO/WHO, 2019); or 30 ng/g 
(tolerance) (Code of Federal Regulations, 2000)— the fipronil egg 
marker residues were well above these MRLs from day 3 in all 
samples taken after oral treatment. To understand the magnitude 
of non- compliant residue levels, the ratios between fipronil egg 
marker residues at each sampling time and MRLs (5; 20 or 30 ng/g) 
were calculated. The ratio values were in the range of 7 to 373 
(MRL: 5 ng/g); 2 to 93 (MRL: 20 ng/g); and 1(Day 3 only) to 62 (tol-
erance: 30 ng/g). Withdrawal period calculations using the results 
of a linear regression analysis of the log residual concentrations vs. 
time of the terminal elimination phase after fipronil administration 
in feed are shown in Figure 4. The suggested withdrawal periods 
are reported in Table 2.
3.2  |  Fipronil topical administration
After fipronil single topical administration (1 mg/kg) to laying hens, 
significant egg residues were quantified (Figure 5). Low fipronil resi-
dues were quantified in egg over the LOQ from day 4 to 16, reaching 
the maximum at day 7 (Cmax: 27.1 ± 4.9 ng/g). The highest egg resid-
ual profile after topical administration corresponded to the fipronil-
 SO2 metabolite, which was quantified from day 4 until the last 
sampling time. Although fipronil- SO2 residual levels observed after 
the topical route were much lower than those observed after the 
administration in feed, the curve profiles had a similar shape. After 
topical treatment, fipronil- SO2 residues also increased from day 4 
to 14, and then egg concentrations remained in a plateau until day 
24, decreasing very slowly afterwards. The Cmax was 163 ± 26 ng/g 
quantified at day 14.
Figure 2 shows the egg fipronil concentration after its top-
ical administration estimated as partial (AUC0- 7 days) or total 
(AUC0- LOQ) area under the curve. Figure 3 shows egg marker res-
idues (fipronil+fipronil- SO2) after fipronil topical administration to 
laying hens. As previously described, as higher concentrations of 
fipronil- SO2 were observed in eggs, the marker residue curve pro-
file was determined by this metabolite. The marker residue Cmax 
F I G U R E  2  Egg residual concentrations as mean AUC (area under 
the curve) (±SD) (ng·day/g) for fipronil (a) and fipronil- SO2 (sulphone 
metabolite) (b) after fipronil administration in feed (two single doses 
of 1 mg kg−1 day−1 at 1 and 7 days) or topical (a single dose of 1 mg 
kg−1 day−1 at day 1) administration to laying hens. Two AUC values 
are shown for each molecule and each treatment route: total AUC 
(AUC0- LOQ) (including two doses) and partial AUC (AUC0- 7 days) 
(including one dose)
(a)





















Partial AUC0-7 daysTotal AUC0-LOQ
(b)




















Partial AUC0-7 daysTotal AUC0-LOQ F I G U R E  3  Mean (±SD) fipronil egg marker residues (sum of 
fipronil parent drug plus fipronil- SO2 (sulphone metabolite)) profile 
vs. time obtained after fipronil administration in feed (two single 
doses of 1 mg kg−1 in feed at days 1 and 7) and topical (one single 
dose of mg kg−1 day−1 at day 1) administration to laying hens. 
*5 ng/g (Commission Regulation EU, 2019); **20 ng/g (FAO/WHO, 
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was 176 ± 30 ng/g. Although fipronil marker residues after topical 
administration were significantly lower than those after oral ad-
ministration, they were also above the mentioned tolerance/MRLs 
(Code of Federal Regulations, 2000; FAO/WHO, 2019; Commission 
Regulation EU, 2019) from day 3 and at all sampling times, with the 
only exception of residue levels at day 3, which were below 20 and 
30 ng/g. The ratios between fipronil marker residues at each sam-
pling time and MRLs were in the range of 3 to 35 (MRL: 5 ng/g); 
0.7(day 3 only) to 9 (MRL: 20 ng/g); or 0.5 (day 3 only) to 6 (tolerance: 
30 ng/g). Withdrawal period calculations using the results of a linear 
regression analysis of the log residual concentrations vs. time of the 
terminal elimination phase after fipronil topical administration are 
shown in Figure 6. The suggested withdrawal periods are reported 
in Table 2.
4  |  DISCUSSION
As mentioned above, the lack of drugs to treat D. gallinae has 
led to the illegal use of substances, such as fipronil. This was 
made evident by the fact that more than one in seven egg and 
chicken samples submitted by member states to EFSA contained 
fipronil residues exceeding legal limits (Reich & Triacchini, 2018). 
In Argentina, fipronil is authorized to treat ectoparasites in cat-
tle and it is available as a ‘pour- on’ formulation (Ectoline®, 1%). 
Therefore, this medication has been a tempting extra- label treat-
ment option for poultry mites. From conversations with workers in 
the industrial poultry sector, we learned that the fipronil formula-
tion is mainly administered orally in feed (Personal communica-
tion). Additionally, topical administration on the back of the hen is 
also used, mainly for domestic production. In the current work, we 
investigated the presence of fipronil/fipronil- SO2 residues in eggs 
after the fipronil extra- label administration to laying hens and sug-
gested a withdrawal period in eggs.
Fipronil has been reported to be widely metabolized in the 
liver by cytochrome P450 (Roques et al., 2012) when admin-
istered to animals, giving fipronil- SO2 as the main metabolite in 
many species, such as mice (Hainzl & Casida, 1996), rats (Cravedi 
et al., 2013), poultry (Stewart, 1994) and humans (Mohamed et al., 
2004). Fipronil can also undergo photolysis to a desulfinyl product 
(fipronil- desulfinyl) (Bobe et al., 1998; Bobe et al., 1998; Ramesh 
& Balsubramanian, 1999; Tomlin, 2000). The long half- life (150– 
245 hr) of fipronil in blood may reveal a slow release of fipronil 
or its metabolites from fat (Gupta & Milatovic, 2014). In addition, 
fipronil- SO2 was shown to persist much longer in blood and tis-
sues than fipronil (Cravedi et al., 2013; Leghait et al., 2009, 2010; 
Roques et al., 2012).
After fipronil administration to laying hens in feed, the drug was 
absorbed and distributed, reaching high residue levels of fipronil in 
egg. Fipronil parent drug was widely metabolized, giving the high-
est fipronil- SO2 concentrations found in egg. Consequently, the 
permanence of fipronil residues was shorter (23 days) than that of 
fipronil- SO2, which was quantified at very high concentrations until 
the end of the sampling period (35 days). This is a relevant finding as 
fipronil- induced toxicity has been fully associated with fipronil- SO2 
metabolite instead of the parent drug (Das et al., 2006; Romero 
et al., 2016).
After its topical administration, firponil was also absorbed and 
metabolized. However, its persistence in egg was shorter (16 days) 
and at lower residual concentrations than those observed after 
F I G U R E  4  Withdrawal period calculations using the results of a linear regression analysis of the log residual concentrations vs. time of the 
terminal elimination phase after fipronil administration in feed (two single doses of 1 mg kg−1 day−1 at 1 and 7 days) to laying hens.. The ‘Melk 
WTM 1.4’ withdrawal- time calculation computer software (http://www.ema.europe.eu) was used. Different MRL or tolerance values were 
considered: 5 ng/g (Commission Regulation EU, 2019) (a); 20 ng/g (FAO/WHO, 2019) (b); 30 ng/g (tolerance) (Code of Federal Regulations, 
2000) (c)
TA B L E  2  Suggested withdrawal period estimated for egg after 
fipronil administration in feed (two single doses of 1 mg kg−1 day−1 
at 1 and 7 days) or topical (one single dose of 1 mg kg−1 day−1 at day 
1) administration to laying hens
MRL/Tolerance
Suggested withdrawal period 
(days)
ORAL TOPICAL
5 ng/g* 206 120
20 ng/g** 166 84
30 ng/g*** 154 74
*5 ng/g (Commission Regulation EU, 2019); 
**20 ng/g (FAO/WHO, 2019); or 
***30 ng/g (Tolerance) (Code of Federal Regulations, 2000). 
F I G U R E  5  Mean (±SD) fipronil and fipronil- SO2 (sulphone 
metabolite) egg residue profile vs. time obtained after fipronil 
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treatment in feed (fipronil ratio Cmax oral in feed/Cmax topical = 8.43). 
Fipronil- SO2 was also the main residue observed until the end of 
sampling, though at a much lower level than that observed after 
fipronil- medicated feed administration (fipronil- SO2 Cmax oral in feed/
Cmax topical ratio = 11.3). These results were expected as two doses 
(1 mg/kg) were administered orally, while a single dose (1 mg/kg) 
was given by the topical route. However, if we consider partial AUC 
from 0 to 7 days (AUC0- 7 days), it represents fipronil egg residue dis-
position after a single administration by either the oral or the topical 
route. When the fipronil partial AUC0- 7 days was compared between 
routes, statistical differences were found (p = 0.0005). The com-
parison of fipronil- SO2 AUC0- 7 days values also showed statistical 
differences (p < 0.0001). Therefore, fipronil residues after topical 
administration were significantly lower than those obtained after 
oral administration in feed.
There is little information available on the fipronil/metabolites 
kinetics and egg residues after fipronil administration to laying hens 
by any route. To our knowledge, only three studies reported fipronil/
metabolite residues in eggs, but fipronil was administered for longer 
periods than that in the current work. When fipronil was adminis-
tered daily at 0.05, 2 or 10 ppm by the oral route (prior to feeding) 
for 28 days (Stewart, 1994), the mean maximum fipronil marker resi-
dues in egg yolk were 180; 7,020 and 30,000 ng/g, one day after the 
end of treatment, respectively. In keeping with the present work, 
the main residue was fipronil- SO2 and it was described as a plateau 
at the end of the study (Stewart, 1994). Although we administered a 
much lower fipronil dose, only two 20 ppm doses in feed one week 
apart, the mean egg marker residue level was also considerable, with 
a Cmax (1,863 ± 866 ng/g) attained at day 22, 15 days after the end 
of treatment. In another trial, laying hens were administered low 
fipronil doses of 0.01 ppm, 0.031 ppm or 0.103 ppm daily in their 
diet for 42 days (Byrd, 1994). Again, fipronil egg residues reached 
a plateau at about 25– 28 days. Although fipronil- SO2 was also the 
main analyte quantified in eggs, the mean levels at the end of the 
study were lower (10, 24 and 96 ng/g) (Byrd, 1994) than those found 
in the present and in the previous work (Stewart, 1994). More re-
cently, we were able to collect samples from a laying hen farm, which 
was apparently administering extra- label fipronil (Ectoline®, 1%). 
Fipronil- SO2 residual concentrations were quantified in yolk with 
a maximum residue level (Cmax) of 2,100 ± 340 ng/g 9 days (tmax) 
after the beginning of treatment (Canton et al., 2018). Although 
total egg samples (not only yolk) were analysed in the present work, 
those residues were in the same range. Anyway, all the reported 
fipronil administrations exceeded the allowed tolerance/MRLs 
(Code of Federal Regulations, 2000; FAO/WHO, 2019; Commission 
Regulation EU, 2019). McCorquodale et al. (1996) gave oral capsules 
of fipronil- desulfinyl at 0.05, 2 and 10 ppm doses to laying hens for 
14 days. In this case, fipronil- desulfinyl was the only residue in egg 
white and yolk, also reaching a plateau. One day after the end of 
the treatments, maximum egg residues for each dose level were 58, 
1550 and 8700 ng/g (McCorquodale et al., 1996).
The long persistence of fipronil residues in egg is explained by 
its high lipophilicity, which determines its accumulation in this tissue 
with high lipid content. In some pet formulations, such as Frontline®, 
fipronil lipophilicity allows drug accumulation in fat and sebaceous 
glands, from which it is slowly released, providing a long action pe-
riod of about 30 days (Frontline technical report, 2013). However, 
the scenario is different for food- producing animals, in which this 
characteristic translates into long withdrawal periods. The fat- 
soluble drug residue kinetics in eggs is peculiar compared to that ob-
served in other edible tissues, in which an equilibrium tissue blood is 
established. Taking into account, the physiology of egg formation al-
lowed us to understand why high fipronil residues were found in the 
egg. Like other described drugs (Donoghue et al., 1997; Marmulak 
et al., 2015; Moreno et al., 2018), fipronil administered to laying 
hens by both routes is absorbed and it reaches the ovary, follicles 
and oviduct. The follicles go through three phases until they become 
eggs. Phase 1 follicles/white follicles are immature without carot-
enoids (Kan & Petz, 2000). The arrival of fipronil residues would be 
significant for follicles that are in phase two/intermediate develop-
ment, between 6 and 2 weeks before the egg is laid. The formation 
of the yolk begins with the arrival through the blood of lipoproteins 
from the liver, which accumulate in the yolk. Similarly, due to its fat 
solubility, fipronil would also arrive from the liver and fatty tissues 
and begin to accumulate within the developing follicle. However, 
the main fipronil accumulation must occur in the final stage of egg 
development (phase 3), between 14 and 10 days before the egg is 
laid because there is a rapid accumulation of yolk lipoproteins. This 
explains why we found high fipronil/metabolite residues in eggs for 
so long even though the fipronil administration was short. For exam-
ple, the follicles that were in stage 2 at the time of the fipronil ad-
ministration received residues directly after absorption, but fipronil 
accumulation continued due to its redistribution from the fatty tis-
sues until the egg was laid approximately 6 weeks later (42 days). 
This is the reason why residues easily exceed the allowed limits after 
fipronil administration to laying hens (Canton et al., 2018; Reich 
& Triacchini, 2018). Certainly, in the current work, fipronil marker 
residues after both oral and topical administrations were above the 
mentioned tolerance/MRLs (Code of Federal Regulations, 2000; 
FAO/WHO, 2019; Commission Regulation EU, 2019). To our knowl-
edge, we estimated for the first time the withdrawal period after 
fipronil administration to laying hens. The residue profiles found 
after both administrations and MRLs were used for calculations, and 
long withdrawal period was obtained. The shortest withdrawal pe-
riods after the topical administration were found to be 74, 84 and 
120 days. These withdrawal periods are close to those indicated for 
F I G U R E  6  Withdrawal period calculations using the results of a linear regression analysis of the log residual concentrations vs. time of 
the terminal elimination phase after fipronil topical (a single dose of 1 mg kg−1 at day 1) administration to laying hens.. The ‘Melk WTM 1.4’ 
withdrawal- time calculation computer software (http://www.ema.europe.eu) was used. Different MRL or tolerance values were considered: 
5 ng/g (Commission Regulation EU, 2019) (a); 20 ng/g (FAO/WHO, 2019) (b); 30 ng/g (tolerance) (Code of Federal Regulations, 2000) (c)
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cattle meat after fipronil ‘pour- on’ administration (Ectoline®), which 
covers 100 days. However, from a practical point of view, fipronil is 
not suitable for use in egg production.
To conclude, the results reported here provide useful infor-
mation on fipronil extra- label treatments to laying hens. Both oral 
and topical administrations led to long time residues in egg. Egg 
residual levels after fipronil administration in feed were signifi-
cantly higher in comparison with the topical treatment. The long 
withdrawal periods estimated after both administrations hinder the 
use of fipronil in egg production. Therefore, its administration to 
laying hens should not be recommended under any circumstances. 
It is important to conduct educational campaigns aimed at poultry 
farmers to avoid fipronil extra- label use. Furthermore, it is crucial 
that the authorities responsible for the control of drug and residues 
in food (applicable to many other countries worldwide) implement 
a strict control of fipronil residues in eggs to guarantee the qual-
ity of this important food source, and therefore, the health of the 
consumer.
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